Marshall Wace North America’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-26,471
Closed -$168K 1923
2018
Q1
$168K Buy
+26,471
New +$168K ﹤0.01% 1349